Back to Report Store Home

Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth

  • Published: May-2013
  • Report Code: GBIHC276MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Travel Vaccines Market, Global, Vaccine Types, 2012

Figure 2: Travel Vaccines Market, Global, Vaccine Manufacturing Process, 2012

Figure 3: Travel Vaccines Market, Top Seven Markets, Revenue Forecast ($m), 2007–2019

Figure 4: Travel Vaccines Market, Top Seven Markets, Market Share by Vaccine Type (%), 2012

Figure 5: Travel Vaccines Market, Top Seven Markets, Market Share by Geography (%), 2012

Figure 6: Travel Vaccines Market, Top Seven Markets, Traveling Population (million), 2007–2019

Figure 7: Travel Vaccines Market, Global, Geographical Distribution of Hepatitis A, 2012

Figure 8: Travel Vaccines Market, US, Hepatitis A Vaccines, Revenue Forecast ($m), 2007–2019

Figure 9: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Revenue Forecast ($m), 2007–2019

Figure 10: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Revenue Forecast ($m), 2007–2019

Figure 11: Travel Vaccines Market, Global, Hepatitis A Vaccines, Pipeline by Phase (%), 2012

Figure 12: Travel Vaccines Market, Global, Geographical Distribution of Hepatitis B, 2012

Figure 13: Travel Vaccines Market, US, Hepatitis B Vaccines, Revenue Forecast ($m), 2007–2019

Figure 14: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Revenue Forecast ($m), 2007–2019

Figure 15: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Revenue Forecast ($m), 2007–2019

Figure 16: Travel Vaccines Market, Global, Hepatitis B Vaccines, Pipeline by Phase (%), 2012

Figure 17: Travel Vaccines Market, Global, Geographical Distribution of Japanese Encephalitis, 2012

Figure 18: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2007–2019

Figure 19: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2007–2019

Figure 20: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2007–2019

Figure 21: Travel Vaccines Market, Global, Japanese Encephalitis Vaccines, Pipeline by Phase (%), 2012

Figure 22: Travel Vaccines Market, Global, Geographical Distribution of Meningococcal Meningitis, 2012

Figure 23: Travel Vaccines Market, US, Meningococcal Vaccines, Revenue Forecast ($m), 2007–2019

Figure 24: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Revenue Forecast ($m), 2007–2019

Figure 25: Travel Vaccines Market, Global, Meningococcal Vaccines, Pipeline by Phase (%), 2012

Figure 26: Travel Vaccines Market, Global, Geographical Distribution of Rabies, 2012

Figure 27: Travel Vaccines Market, US, Rabies Vaccines, Revenue Forecast ($m), 2007–2019

Figure 28: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Revenue Forecast ($m), 2007–2019

Figure 29: Travel Vaccines Market, Japan. Rabies Vaccines, Revenue Forecast ($m), 2007–2019

Figure 30: Travel Vaccines Market, Global, Rabies Vaccines, Pipeline by Phase (%), 2012

Figure 31: Travel Vaccines Market, Global, Geographical Distribution of Typhoid, 2012

Figure 32: Travel Vaccines Market, US, Typhoid Vaccines, Revenue Forecast ($m), 2007–2019

Figure 33: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Revenue Forecast ($m), 2007–2019

Figure 34: Travel Vaccines Market, Global, Typhoid Vaccines, Pipeline by Phase (%), 2012

Figure 35: Travel Vaccines Market, Global, Geographical Distribution of Yellow Fever, 2012

Figure 36: Travel Vaccines Market, US, Yellow Fever Vaccines, Revenue Forecast ($m), 2007–2019

Figure 37: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Revenue Forecast ($m), 2007–2019

Figure 38: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Revenue Forecast ($m), 2007–2019

Figure 39: Travel Vaccines Market, Global, Yellow Fever Vaccines, Pipeline by Phase (%), 2012

Figure 40: GlaxoSmithKline, Travel Vaccines Market, SWOT Analysis, 2012

Figure 41: Sanofi, Travel Vaccines Market, SWOT Analysis, 2012

Figure 42: Pfizer, Travel Vaccines Market, SWOT Analysis, 2012

Figure 43: Merck, Travel Vaccines Market, SWOT Analysis, 2012

Figure 44: Novartis, Travel Vaccines Market, SWOT Analysis, 2012

Figure 45: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Year, 2009–2013

Figure 46: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Type, 2008–2013

Figure 47: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Value, 2008–2013

Figure 48: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Geography, 2008–2013

Figure 49: Vaccines in Emerging Markets, India, National Rural Health Mission, 2011

Figure 50: Vaccines in Emerging Markets, Deals by Year, 2009–2013

Figure 51: Travel Vaccines Market, Emerging Markets, Deals by Type (%), 2009–2013

Figure 52: Travel Vaccines Market, Emerging Markets, Deals by Value ($m), 2009–2013

Figure 53: Travel Vaccines Market, Emerging Markets, Pipeline by Phase (%), 2012

Figure 54: GBI Research Market Forecasting Model

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards